Literature DB >> 35763255

Carfilzomib-related glomerular and tubular injury in a patient with Multiple Myeloma.

Domenico Giannese1, Angelo Giovanni Bonadio2, Maria Lavinia Del Giudice3, Adamasco Cupisti4, Gabriele Buda3.   

Abstract

Entities:  

Keywords:  Carfilzomib; Kidney biopsy; Multiple myeloma; Secondary glomerulonephritis

Mesh：

Substances：

Year:  2022        PMID： 35763255     DOI： 10.1007/s40620-022-01367-0

Source DB:  PubMed          Journal:  J Nephrol        ISSN： 1121-8428            Impact factor:   4.393


× No keyword cloud information.
  5 in total

1.  Proteasome Inhibitor Drugs.

Authors:  Lloyd D Fricker
Journal:  Annu Rev Pharmacol Toxicol       Date:  2019-09-03       Impact factor: 13.820

2.  Risk of kidney toxicity with carfilzomib in multiple myeloma: a meta-analysis of randomized controlled trials.

Authors:  Somedeb Ball; Tapas Ranjan Behera; Faiz Anwer; Rajshekhar Chakraborty
Journal:  Ann Hematol       Date:  2020-05-07       Impact factor: 3.673

3.  Proteasome inhibitor associated thrombotic microangiopathy.

Authors:  Jennifer C Yui; Jan Van Keer; Brendan M Weiss; Adam J Waxman; Matthew B Palmer; Vivette D D'Agati; Efstathios Kastritis; Meletios A Dimopoulos; Ravi Vij; Dhruv Bansal; David Dingli; Samih H Nasr; Nelson Leung
Journal:  Am J Hematol       Date:  2016-07-04       Impact factor: 10.047

4.  Acute Tubular Necrosis in a Patient With Myeloma Treated With Carfilzomib.

Authors:  Vladimir Liberman; Vivette D D'Agati; Naveed N Masani; James Drakakis; Joseph Mattana
Journal:  Kidney Int Rep       Date:  2016-06-23

5.  Carfilzomib-associated renal toxicity is common and unpredictable: a comprehensive analysis of 114 multiple myeloma patients.

Authors:  Despina Fotiou; Maria Roussou; Charikleia Gakiopoulou; Erasmia Psimenou; Maria Gavriatopoulou; Magdalini Migkou; Nikolaos Kanellias; Ioanna Dialoupi; Evangelos Eleutherakis-Papaiakovou; Stavroula Giannouli; Christina Delavinia; Kostantinos Efstathiou; Sofoklis Kontogiannis; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis
Journal:  Blood Cancer J       Date:  2020-11-03       Impact factor: 11.037
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.